209 related articles for article (PubMed ID: 7728738)
1. Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients.
Subramaniam S; Subramaniam S; Shyamala Devi CS
Cancer Biochem Biophys; 1994 Oct; 14(3):177-82. PubMed ID: 7728738
[TBL] [Abstract][Full Text] [Related]
2. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease.
Polat MF; Taysi S; Gul M; Cikman O; Yilmaz I; Bakan E; Erdogan F
Cell Biochem Funct; 2002 Dec; 20(4):327-31. PubMed ID: 12415567
[TBL] [Abstract][Full Text] [Related]
3. Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer.
Kumar K; Thangaraju M; Sachdanandam P
Biochem Int; 1991 Sep; 25(2):371-80. PubMed ID: 1789800
[TBL] [Abstract][Full Text] [Related]
4. Effect of tamoxifen on erythrocyte membrane lipids, lipid peroxides, and antioxidative enzymes in breast cancer women.
Thangaraju M; Ezhilarasi R; Sachdanandam P
Cancer Biochem Biophys; 1995 Jan; 14(4):297-302. PubMed ID: 7767903
[TBL] [Abstract][Full Text] [Related]
5. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide.
Kasapović J; Pejić S; Stojiljković V; Todorović A; Radošević-Jelić L; Saičić ZS; Pajović SB
Clin Biochem; 2010 Nov; 43(16-17):1287-93. PubMed ID: 20713039
[TBL] [Abstract][Full Text] [Related]
7. Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities.
Jendryczko A; Tomala J; Janosz P
Zentralbl Gynakol; 1993; 115(11):469-72. PubMed ID: 8296490
[TBL] [Abstract][Full Text] [Related]
8. Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age.
Oztürk O; Gümüşlü S
Exp Gerontol; 2004 Feb; 39(2):211-6. PubMed ID: 15036414
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell metabolism in experimental animals: pentose phosphate pathway, antioxidant enzymes and glutathione.
Suzuki T; Agar NS; Suzuki M
Jikken Dobutsu; 1985 Oct; 34(4):353-66. PubMed ID: 3910443
[No Abstract] [Full Text] [Related]
10. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy.
Suhail N; Bilal N; Khan HY; Hasan S; Sharma S; Khan F; Mansoor T; Banu N
J Clin Pharm Ther; 2012 Feb; 37(1):22-6. PubMed ID: 21204889
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages.
Kasapović J; Pejić S; Todorović A; Stojiljković V; Pajović SB
Cell Biochem Funct; 2008 Aug; 26(6):723-30. PubMed ID: 18636415
[TBL] [Abstract][Full Text] [Related]
13. HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
Di Leo A; Gancberg D; Larsimont D; Tanner M; Jarvinen T; Rouas G; Dolci S; Leroy JY; Paesmans M; Isola J; Piccart MJ
Clin Cancer Res; 2002 May; 8(5):1107-16. PubMed ID: 12006526
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant defence system of erythrocytes in relation to Agrobacterium tumefaciens lipopolysaccharide administration in mice.
Haldar S; Basu A; Chakraborty K; Addya S; Santra M; Chatterjee GC
Indian J Exp Biol; 1984 Mar; 22(3):123-5. PubMed ID: 6519684
[No Abstract] [Full Text] [Related]
15. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type I and II alcoholics.
Uçar G; Demir B; Uluğ B
Cell Biochem Funct; 2005; 23(1):29-37. PubMed ID: 15386540
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
[TBL] [Abstract][Full Text] [Related]
17. Alterations in erythrocyte membrane structure of breast cancer patients treated with CMF--a lipid profile.
Subramaniam S; Subramaniam S; Jagadeesan M; Devi CS
Chemotherapy; 1994; 40(6):427-30. PubMed ID: 7842827
[TBL] [Abstract][Full Text] [Related]
18. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
19. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with pregnancy--induced hypertension.
Krishna Mohan S; Venkataramana G
Indian J Physiol Pharmacol; 2007; 51(3):284-8. PubMed ID: 18341226
[TBL] [Abstract][Full Text] [Related]
20. [Status of the antioxidant system of erythrocytes in newborn infants in acute and chronic hypoxia].
Dubinina EE; Sofronova LN; Ramenskaia NP; Efimova LF; Petrova ZA
Vopr Med Khim; 1989; 35(1):56-9. PubMed ID: 2545043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
